MedPath

Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention

Not Applicable
Recruiting
Conditions
HIV-infection/Aids
Domestic Violence
Alcohol Use Disorder
Intimate Partner Violence
Interventions
Behavioral: Screening and Referral
Behavioral: Kisoboka Mukwano ("It is possible, my love!") Intervention
Registration Number
NCT05947539
Lead Sponsor
Arizona State University
Brief Summary

This study will develop and pilot test a couples-based intervention to help adolescent girls and young women living with HIV (WLHIV (15-24 years) living in Uganda access HIV care and improve the outcomes of their HIV treatment by targeting male partner alcohol use to reduce IPV risk.

Detailed Description

In Uganda, adolescent girls and young women (AGYW) are disproportionately affected by HIV and have poor viral suppression rates, increasing their risk of onward transmission. Intimate partner violence (IPV) is a major barrier to mitigating the impact of HIV among AGYW. AGYW living with HIV (AGYWLHIV) in sub-Saharan Africa (SSA) who have experienced IPV have worse medication adherence, viral suppression, and care engagement than those without IPV. Further, male partner alcohol use directly and indirectly increases IPV risk among AGYW in SSA. Thus, an intervention with components that address heavy alcohol use among male partners could decrease AGYW's IPV risk, especially in Uganda, which has the highest alcohol use per capita in SSA. Couples- based interventions have effectively reduced male partner alcohol use, relationship conflict IPV, and improved viral suppression and HIV care engagement; yet, none have been tailored to AGYWLHIV in SSA. The investigators propose to develop and pilot a couples-based intervention that focuses on improving HIV care engagement and ART adherence among AGYWLHIV by reducing heavy alcohol use among male partners and couple IPV risk. Additionally, the investigators will explore the intervention's effects on AGYW viral load for the additional key benefit of treatment as prevention. The study aims are to: 1) Adapt the behavioral components of a brief Motivational Interviewing (MI)-based alcohol intervention to create the proposed Kisoboka Mukwano ("It is possible, my love!") intervention. The intervention will promote strategies for reductions in male partner alcohol use, coping with relationship conflict and stress, changing norms that reduce IPV and support engagement in HIV care and ART adherence among AGYWLHIV, and, thereby, enhance future sustained viral suppression and benefits of treatment as prevention. The intervention will be adapted and tailored to be delivered with heterosexual couples, involve peer navigators, address IPV, and be developmentally appropriate for AGYWLHIV in Uganda. The investigators will develop and refine the intervention in collaboration with an intervention steering committee through: qualitative research with married/cohabiting AGYWLHIV, married/cohabiting men, and key informants and an initial pilot test with 6 couples. 2) The investigators will assess safety, acceptability, feasibility, and preliminary estimates of the potential for the intervention, as compared to the control group, to improve HIV, alcohol, and IPV outcomes. The investigators will examine preliminary effects on AGYW HIV care engagement, AGYW ART adherence, heavy alcohol use among male partners, and couple IPV risk and explore effects on AGYW viral load as well as intermediate outcomes related to intervention components. The investigators will assess these outcomes at baseline and then at 3- and 6-month follow-up. Study findings will be used to guide a subsequent R01 proposal to test the intervention in a larger clinical trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Screening & Referral (control)Screening and ReferralBrief feedback on intimate partner violence and alcohol use (males), referrals for these conditions, and briefly discuss the importance of HIV care engagement and adherence.
Kisoboka Mukwano Intervention (treatment)Kisoboka Mukwano ("It is possible, my love!") InterventionA brief couples-based intervention using motivational interviewing, peer navigation, and behavioral economic approaches to target intimate partner violence, alcohol use, and HIV care engagement.
Primary Outcome Measures
NameTimeMethod
change from baseline in self-reported antiretroviral therapy (ART) adherence (females and HIV+ male partners)3 and 6 month follow up

Self- report of missed ART using the AIDS Clinical Trials Group Adherence (AACTG) measures

change from baseline in antiretroviral therapy (ART) adherence biomarker (females and HIV+ male partners)3 and 6 month follow up

presence of Tenofoivir Disoproxil Fumarate (TDF) detected in urine

change from baseline in heavy drinking (male partners)3 months, 6 months

assessed with the Alcohol Use Disorders Identification Test (AUDIT-C)

change from baseline in HIV care engagement (females and HIV+ male partners)3 months, 6 months

HIV clinic visit adherence

change from baseline in phosphatidylethanol (PEth) (male partners)6 months

alcohol biomarker (PEth) levels

Intimate partner violence (IPV) occurence (males and females)6 months

Any incident of IPV perpetration and victimization: physical, sexual, verbal/emotional, intimidation and/or controlling behavior measured using the World Health Organization (WHO) Instrument/ Demographic and Health Data (DHS) Domestic Violence Modules.

Secondary Outcome Measures
NameTimeMethod
Fear of intimate partner violence (males and females)6 month follow up

Rating of how often one is afraid of their current spouse/partner measured using the WHO Instrument/ DHS Domestic Violence Modules.

Trial Locations

Locations (1)

Makerere Univerisity School of Public Health

🇺🇬

Kampala, Uganda

© Copyright 2025. All Rights Reserved by MedPath